The Benefits Of Novel PSA Velocity Risk Count Testing For Prostate Cancer
A new study by NYU Langone Medical Center and Northwestern University Feinberg School of Medicine shows novel PSA velocity (PSAV) risk count testing may provide a more effective way for physicians to screen men for clinically significant prostate cancer. The new study, published online by the British Journal of Urology Internationa shows the benefits of tracking a man's PSA levels over time to help doctors more accurately assess his risk of life-threatening prostate cancer... (Source: Health News from Medical News Today)
Smartphones Drive Mobile Health
Source: John Pulley, NextGov Content: #8220;A population that is on the move will increasingly turn to mobile health applications, predicts a new market study.
The Hampshire, England-based Juniper Research Ltd. projects that mobile networks will monitor 3 million patients by 2016, according to a company news release. The growth will be fueled in part by increasingly [...] (Source: ICMCC: The International Council on Medical and Care Compunetics)
